Cargando…

Bone Marrow-Sparing IMRT in Anal Cancer Patients Undergoing Concurrent Chemo-Radiation: Results of the First Phase of a Prospective Phase II Trial

SIMPLE SUMMARY: Hematological toxicity may be a consistent issue in anal cancer patients undergoing concurrent chemo-radiation, with a potentially detrimental effect on clinical outcomes and patient compliance to treatment. Chemotherapy is the most important trigger, since it induces myelosuppressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arcadipane, Francesca, Silvetti, Patrick, Olivero, Francesco, Gastino, Alessio, De Luca, Viola, Mistrangelo, Massimiliano, Cassoni, Paola, Racca, Patrizia, Gallio, Elena, Lesca, Adriana, Fiandra, Christian, Ricardi, Umberto, Franco, Pierfrancesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696305/ https://www.ncbi.nlm.nih.gov/pubmed/33182445 http://dx.doi.org/10.3390/cancers12113306

Ejemplares similares

Concurrent Chemoradiation in Anal Cancer Patients Delivered with Bone Marrow-Sparing IMRT: Final Results of a Prospective Phase II Trial
por: Arcadipane, Francesca, et al.
Publicado: (2021)

The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer
por: Franco, Pierfrancesco, et al.
Publicado: (2018)

Incorporating (18)FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation
por: Franco, Pierfrancesco, et al.
Publicado: (2017)

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier)
por: Casadei-Gardini, Andrea, et al.
Publicado: (2019)

Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study
por: Franco, Pierfrancesco, et al.
Publicado: (2018)

Value of staging squamous cell carcinoma of the anal margin and canal using the sentinel lymph node procedure: an update of the series and a review of the literature
por: Mistrangelo, D M, et al.
Publicado: (2013)

The Prognostic Value of the New Combined Hemo-Eosinophil Inflammation Index (HEI Index): A Multicenter Analysis of Anal Cancer Patients Treated with Concurrent Chemo-Radiation
por: Rimini, Margherita, et al.
Publicado: (2021)

Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin’s lymphoma: dosimetric comparison and clinical considerations
por: Fiandra, Christian, et al.
Publicado: (2012)

A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes
por: Miah, A B, et al.
Publicado: (2015)

Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans
por: Menkarios, Cathy, et al.
Publicado: (2007)

Prospective evaluation of dose-escalated preoperative concurrent chemo-radiation with image guided-IMRT in locally advanced rectal cancers
por: Puri, Raunaq, et al.
Publicado: (2023)

Radiation therapy for oligometastatic oropharyngeal cancer
por: Martini, Stefania, et al.
Publicado: (2020)

The Prognostic Role of Baseline Eosinophils in HPV-Related Cancers: a Multi-institutional Analysis of Anal SCC and OPC Patients Treated with Radical CT-RT
por: Rimini, Margherita, et al.
Publicado: (2022)

Brain-Sparing Methods for IMRT of Head and Neck Cancer
por: Dunlop, Alex, et al.
Publicado: (2015)

Dose Escalation of Lobaplatin Concurrent with IMRT for the Treatment of Stage III-IVb NPC: A Phase I Clinical Trial()()
por: Wang, Si-Yang, et al.
Publicado: (2018)

IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinoma
por: Zhong, Qiulu, et al.
Publicado: (2017)

IMRT sparing of normal tissues in locoregional treatment of breast cancer
por: Caudrelier, Jean-Michel, et al.
Publicado: (2014)

Comparison of dosimetric data of bone marrow between standard IMRT and bone marrow sparing IMRT in carcinoma cervix
por: Pattanayak, Lucy, et al.
Publicado: (2021)

IMRT, RapidArc® and conformal radiotherapy in the treatment of tumours of the anal canal
por: Cendales, Ricardo, et al.
Publicado: (2014)

Clinical experience of SIB-IMRT in anal cancer and selective literature review
por: Janssen, Stefan, et al.
Publicado: (2014)

Cetuximab concurrent with IMRT versus cisplatin concurrent with IMRT in locally advanced nasopharyngeal carcinoma: A retrospective matched case–control study
por: Wu, Xin, et al.
Publicado: (2016)

Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e
por: Franco, Pierfrancesco, et al.
Publicado: (2018)

Modern Stereotactic Radiotherapy for Brain Metastases from Lung Cancer: Current Trends and Future Perspectives Based on Integrated Translational Approaches
por: Levis, Mario, et al.
Publicado: (2023)

IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center
por: Vieillot, Sabine, et al.
Publicado: (2012)

Dose planning objectives in anal canal cancer IMRT: the TROG ANROTAT experience
por: Brown, Elizabeth, et al.
Publicado: (2015)

Phase I/II study of induction chemotherapy plus concurrent chemotherapy and SMART-IMRT-based radiotherapy in locoregionally-advanced nasopharyngeal cancer
por: FAN, TING-YONG, et al.
Publicado: (2013)

CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer
por: Cai, Gang, et al.
Publicado: (2015)

A phase II trial of preoperative concurrent chemotherapy and dose escalated intensity modulated radiotherapy (IMRT) for locally advanced rectal cancer
por: Tey, Jeremy, et al.
Publicado: (2017)

Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
por: Ursino, Stefano, et al.
Publicado: (2022)

Squamous cell carcinoma of the prostate: long-term survival after combined chemo-radiation
por: Munoz, Fernando, et al.
Publicado: (2007)

Chemo-radiotherapy induced oral mucositis during IMRT for head and neck cancer - An assessment
por: Nagarajan, Karthika
Publicado: (2015)

High-dose concurrent chemo–proton therapy for Stage III NSCLC: preliminary results of a Phase II study
por: Oshiro, Yoshiko, et al.
Publicado: (2014)

A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix
por: Yuan, Guangwen, et al.
Publicado: (2014)

Intensity-Modulated Radiotherapy (IMRT) vs Helical Tomotherapy (HT) in Concurrent Chemoradiotherapy (CRT) for Patients with Anal Canal Carcinoma (ACC): an analysis of dose distribution and toxicities
por: Yeung, Rosanna, et al.
Publicado: (2015)

YKL-40/c-Met Expression in Rectal Cancer Biopsies Predicts Tumor Regression following Neoadjuvant Chemoradiotherapy: A Multi-Institutional Study
por: Senetta, Rebecca, et al.
Publicado: (2015)

Defining the dose‐volume criteria for laryngeal sparing in locally advanced oropharyngeal cancer utilizing split‐field IMRT, whole‐field IMRT and VMAT
por: Wilke, Christopher, et al.
Publicado: (2020)

Cerebral cortex dose sparing for glioblastoma patients: IMRT versus robust treatment planning
por: Exeli, Ann-Katrin, et al.
Publicado: (2018)

Quantifying target-specific motion in anal cancer patients treated with intensity modulated radiotherapy (IMRT)
por: Durrant, Lisa, et al.
Publicado: (2016)

Modern Radiation Therapy for the Management of Brain Metastases From Non-Small Cell Lung Cancer: Current Approaches and Future Directions
por: Mantovani, Cristina, et al.
Publicado: (2021)

Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial
por: Guberina, N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_og70h3pb1830ec9mm0599la4r7